Aptus Capital Advisors’s Xilio Therapeutics XLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17K	Sell	25,000 -21,000	-46%	-$14.3K	﹤0.01%	1299
2025 Q1	$33.3K	Buy	46,000 +5,000	+12%	+$3.62K	﹤0.01%	1145
2024 Q4	$39.2K	Buy	+41,000	New	+$39.2K	﹤0.01%	1134